Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
enterobiasis
MeSH D017229 - enterobiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010123:
Oxyuriasis
0 Companies
0 Drugs
Success rate
D017229:
Enterobiasis
24 Companies
4 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Cipla
Albendazole
Albendazole
2018-09-21
Dr Reddys Laboratories
Albendazole
Albendazole
2021-01-26
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
100
%
5/5
Approved:
5
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Ivermectin
Padagis
Ivermectin
Taro Pharmaceutical
Ivermectin
Johnson & Johnson
Mebendazole
Zydus Therapeutics
Ivermectin
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use